Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03328650 · ClinicalTrials.gov registry record
Clinical Outcomes of the ALPS Proximal Humerus Plating System
A clinical trial of Proximal Humeral Fracture, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT03328650: Recruiting study of Proximal Humeral Fracture, sponsored by Vanderbilt University Medical Center.
NCT03328650 is a study of Proximal Humeral Fracture that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 150 participants, above the 109-participant average among 3 other Proximal Humeral Fracture trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03328650, a study of Proximal Humeral Fracture, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to document the performance and clinical outcomes of the A.L.P.S® Proximal Humerus Plating System. Specific Aims: * Conduct physical assessments measuring shoulder strength and range of motion, physician assessment of radiographs * Obtain patient-reported outcomes regarding pain level, function capabilities, and work/leisure restrictions * Document revisions, complications, and adverse events
Primary Outcome
Measured by the Osteoprobe
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt Orthopaedics - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2017-08-07 |
| Est. Completion | 2031-12-01 |
What NCT03328650 shows while recruiting
NCT03328650 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 109-participant average among 3 other Proximal Humeral Fracture trials with a reported enrollment target (38% higher).
The record links to 1 condition, with Proximal Humeral Fracture appearing as the primary indexed condition, and to 0 interventions.
NCT03328650 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03328650 about?
NCT03328650 is a clinical study titled "Clinical Outcomes of the ALPS Proximal Humerus Plating System". The purpose of this study is to document the performance and clinical outcomes of the A.L.P.S® Proximal Humerus Plating System. Specific Aims: * Conduct physical assessments measuring shoulder strength and range of motion, physician assessment of radiographs * Obtain patient-reported outcomes rega...
What is the current status of trial NCT03328650?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2017-08-07. Estimated completion is 2031-12-01.
What conditions does trial NCT03328650 study?
This clinical trial studies the following conditions: Proximal Humeral Fracture.
Who is sponsoring clinical trial NCT03328650?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03328650 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Proximal Humeral Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
RECRUITING
-
Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
RECRUITING
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI